Billy Tauzin, who for the past five years has been the influential leader of the powerful US pharmaceutical industry body, PhRMA, is to step down as president on 30 June to explore “many other interests”.
Mr Tauzin will remain as president while a replacement is sought, and he “will continue to serve in a consultancy role afterwards”, PhRMA said in a statement1...
Please login to read the full article.
